Status:
COMPLETED
GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients
Lead Sponsor:
AgNovos Healthcare, LLC
Conditions:
Osteoporosis
Eligibility:
All Genders
Brief Summary
The study is designed as a retrospective, single-center study for subjects previously treated with the AGN1 LOEP Kit. This will be a non-randomized and non-blinded study. The study will collect retros...
Eligibility Criteria
Inclusion
- Subject has previously received AGN1 LOEP treatment between September 2019 and November 2022.
- Subject has willingness to participate in the study.
- Subject can give written informed consent to allow for data collection.
Exclusion
- The subject's AGN1 LOEP treatment was previously performed as part of a prior protocoled clinical study.
Key Trial Info
Start Date :
December 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 3 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05966974
Start Date
December 15 2022
End Date
April 3 2023
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vitaz
Sint-Niklaas, Belgium, 9100